139 related articles for article (PubMed ID: 37920449)
1. Lactate dehydrogenase predicts disease progression outcome in COVID-19 patients treated with Azvudine.
Mao M; Dian Y; Sun Y; Chen W; Zhu W; Deng G
Front Cell Infect Microbiol; 2023; 13():1237277. PubMed ID: 37920449
[TBL] [Abstract][Full Text] [Related]
2. Association of eosinopenia with worsening prognosis in hospitalized Azvudine-treated COVID-19 patients: a retrospective cohort study.
Wang X; Dian Y; Zhou Q; Deng G; Wei R; Zeng F
Front Immunol; 2023; 14():1320973. PubMed ID: 38162638
[TBL] [Abstract][Full Text] [Related]
3. Real-world effectiveness of Azvudine versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19: A retrospective cohort study.
Deng G; Li D; Sun Y; Jin L; Zhou Q; Xiao C; Wu Q; Sun H; Dian Y; Zeng F; Pan P; Shen M
J Med Virol; 2023 Apr; 95(4):e28756. PubMed ID: 37185838
[TBL] [Abstract][Full Text] [Related]
4. Oral azvudine for mild-to-moderate COVID-19 in high risk, nonhospitalized adults: Results of a real-world study.
Yang H; Wang Z; Jiang C; Zhang Y; Zhang Y; Xu M; Zhang Y; Wang Y; Liu X; An Z; Tong Z
J Med Virol; 2023 Jul; 95(7):e28947. PubMed ID: 37470209
[TBL] [Abstract][Full Text] [Related]
5. 'Immune-inflammatory markers & clinical characteristics for outcomes in hospitalized SARS-CoV-2 infected patients of Pakistan: a retrospective analysis'.
Khalid A; Aqeel RF; Nawaz A; Ahmad J; Fatima ST; Shahid S; Rao AA; Aktas G; Ijaz S; Shehryar M
Hematology; 2023 Dec; 28(1):2199629. PubMed ID: 37408482
[TBL] [Abstract][Full Text] [Related]
6. Association of diabetes mellitus with disease severity and prognosis in COVID-19: A retrospective cohort study.
Zhang Y; Cui Y; Shen M; Zhang J; Liu B; Dai M; Chen L; Han D; Fan Y; Zeng Y; Li W; Lin F; Li S; Chen X; Pan P;
Diabetes Res Clin Pract; 2020 Jul; 165():108227. PubMed ID: 32446795
[TBL] [Abstract][Full Text] [Related]
7. Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study.
Sun Y; Jin L; Dian Y; Shen M; Zeng F; Chen X; Deng G
EClinicalMedicine; 2023 May; 59():101981. PubMed ID: 37193346
[TBL] [Abstract][Full Text] [Related]
8. Head-to-head comparison of azvudine and nirmatrelvir/ritonavir for the hospitalized patients with COVID-19: a real-world retrospective cohort study with propensity score matching.
Wei AH; Zeng L; Wang L; Gui L; Zhang WT; Gong XP; Li J; Liu D
Front Pharmacol; 2023; 14():1274294. PubMed ID: 37900159
[No Abstract] [Full Text] [Related]
9. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
[TBL] [Abstract][Full Text] [Related]
10. [Clinical features and risk factors for secondary hemophagocytic lymphohistiocytosis in elderly patients with severe SARS-CoV-2 infection: a multicenter retrospective cohort study].
Deng Y; Lu S; Zhang G; Sun W; Chu Y; Meng M; Cui Y; Li P
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Aug; 35(8):793-799. PubMed ID: 37593855
[TBL] [Abstract][Full Text] [Related]
11. A Retrospective Analysis of Azvudine in Patients with COVID-19 and Pre-existing Cancer.
Li F; Zheng K; Qi X; Cui K; Yang J; Hao Z
J Cancer; 2024; 15(8):2442-2447. PubMed ID: 38495484
[No Abstract] [Full Text] [Related]
12. Inflammatory predictors (eosinophil, C-RP and IL-6) and effectiveness of oral Azvudine tablets treatment in COVID-19 hospitalized patients: A retrospective, self-controlled study.
Zhao Y; Gao G; Li W; Xu Z; Wang X; Chang R
Heliyon; 2023 Nov; 9(11):e21941. PubMed ID: 38034620
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of lactate dehydrogenase for in-hospital mortality in severe and critically ill patients with COVID-19.
Dong X; Sun L; Li Y
Int J Med Sci; 2020; 17(14):2225-2231. PubMed ID: 32922185
[No Abstract] [Full Text] [Related]
14. Impact of serum lactate dehydrogenase on the short-term prognosis of COVID-19 with pre-existing cardiovascular diseases.
Masumoto A; Kitai T; Matsumoto S; Kuroda S; Kohsaka S; Tachikawa R; Seo R; Doi A; Tomii K; Yonetsu T; Torii S; Komuro I; Hirata KI; Node K; Matsue Y; Furukawa Y
J Cardiol; 2022 Apr; 79(4):501-508. PubMed ID: 35000825
[TBL] [Abstract][Full Text] [Related]
15. Early predictors for mechanical ventilation in COVID-19 patients.
Li W; Lin F; Dai M; Chen L; Han D; Cui Y; Pan P
Ther Adv Respir Dis; 2020; 14():1753466620963017. PubMed ID: 33054630
[TBL] [Abstract][Full Text] [Related]
16. Azvudine versus paxlovid for oral treatment of COVID-19 in Chinese patients.
Su P; Yang CX; Wang XG
BMC Infect Dis; 2024 Jan; 24(1):44. PubMed ID: 38172735
[TBL] [Abstract][Full Text] [Related]
17. Clinical and inflammatory features based machine learning model for fatal risk prediction of hospitalized COVID-19 patients: results from a retrospective cohort study.
Guan X; Zhang B; Fu M; Li M; Yuan X; Zhu Y; Peng J; Guo H; Lu Y
Ann Med; 2021 Dec; 53(1):257-266. PubMed ID: 33410720
[TBL] [Abstract][Full Text] [Related]
18. High serum lactate dehydrogenase and dyspnea: Positive predictors of adverse outcome in critical COVID-19 patients in Yichang.
Lv XT; Zhu YP; Cheng AG; Jin YX; Ding HB; Wang CY; Zhang SY; Chen GP; Chen QQ; Liu QC
World J Clin Cases; 2020 Nov; 8(22):5535-5546. PubMed ID: 33344544
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of azvudine in reducing mortality of COVID-19 patients: a systematic review and meta-analysis.
Wang Y; Xie H; Wang L; Fan J; Zhang Y; Pan S; Zhou W; Chen Q; Liu X; Wu A; Zhang H; Wang J; Tian X
Virol J; 2024 Feb; 21(1):46. PubMed ID: 38395970
[TBL] [Abstract][Full Text] [Related]
20. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
